SCHEMBL19617837

SCHEMBL19617837

C=C(C(=O)c1ncnc2c1CCNC2)N1CCNCC1

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.31
KCNH2 Q12809 1/20 0.31
SIGMAR1 Q99720 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19617838 0.85 SIGMAR1 (0.30) KDRSIGMAR1
SCHEMBL19617745 0.78
SCHEMBL4984720 0.75 TSHR (0.33) KDRKCNH2
SCHEMBL19617841 0.74 SMARCA4 (0.33) KDRKCNH2
SCHEMBL21036409 0.74 CD44 (0.30) KDR
Trifluoroacetic Acid SCHEMBL21003170 0.71 KDR (0.33) KDRKCNH2
SCHEMBL21319813 0.68 DRD2 (0.45)
SCHEMBL29428699 0.65 KDM4E (0.33) KDRKCNH2
SCHEMBL17298716 0.65 KDM4E (0.33) KDRKCNH2
SCHEMBL23174573 0.65 MKNK2 (0.33) KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458445-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2019-03-27 EP disclosed
WO-2017201161-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2017-11-23 WO disclosed